Characterisation of Pseudomonas aeruginosa related to bovine mastitis

Acta Veterinaria Hungarica

Volumn 62, Issue 1, 2014, Pages 1-12

  Park, Hye ^a   Hong, Min ^b   Hwang, Sun ^a   Park, Young ^a   Kwon, Ka ^a   Yoon, Jang ^a   Shin, Sook ^a   Kim, Jae ^a   Park, Yong ^a  

^a Seoul National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

biofilm; bovine mastitis; minimum biofilm eradication concentration (MBEC); Pseudomonas aeruginosa; type three secretion system (TTSS)

Indexed keywords

EID: 84897805029     PISSN: 02366290     EISSN: 15882705     Source Type: Journal    
DOI: 10.1556/AVet.2013.054     Document Type: Article

References (23)

1. CLSI (2012): Performance Standards for Antimicrobial Susceptibility Testing. 22nd Informational Supplement. M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA, USA.
2. Des Haas, Y., Barkema, H. W., Schukken, Y. H. and Veerkamp, R. F. (2005): Association between somatic cell count patterns and the incidence of clinical mastitis. Prev. Vet. Med. 67, 55-68.
3. Engel, J. and Balachandran, P. (2009): Role of Pseudomonas aeruginosa type III effectors in disease. Curr. Opin. Microbiol. 12, 61-66.
4. Fleiszig, S., Wiener-Kronish, J. P., Miyazaki, H., Vallas, V., Mostov, K. E., Kanada, D., Sawa, T., Yen, T. and Frank, D. W. (1997): Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect. Immun. 65, 579-586.
5. Hillerton, J. E. and Kliem, K. E. (2002): Effective treatment of Streptococcus uberis clinical mastitis to minimize the use of antibiotics. J. Dairy Sci. 85, 1009-1014.
6. Jung, S. C., Lim, S. K., Lee, H. S., Jung, B. Y., Lee, J. Y., Yang, C. B. and Shin, H. C. (2008): Antibiotics use in animal and resistant bacteria. Infect. Chemother. 40, 144-149.
7. Ko, K. S., Suh, J. Y., Kwon, K. T., Jung, S.-I., Park, K.-H., Kang, C. I., Chung, D. R., Peck, K. R. and Song, J.-H. (2007): High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J. Antimicrob. Chemoth. 60, 1163-1167.
8. Ledbetter, E. C., Mun, J. J., Kowbel, D. and Fleiszig, S. M. J. (2009): Pathogenic phenotype and genotype of Pseudomonas aeruginosa isolates from spontaneous canine ocular infections. Invest. Ophthalmol. Vis. Sci. 50, 729-736.
9. Lyczak, J. B., Cannon, C. L. and Pier, G. B. (2000): Establishment of Pseudomonas aeruginosa in-fection: lessons from a versatile opportunist. Microbes Infect. 2, 1051-1060.
10. Magiorakos, A. P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G. and Olsson-Liljequist, B. (2012): Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18, 268-281.
11. Mah, T. F. C. and O'Toole, G. A. (2001): Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9, 34-39.
12. Melchior, M., Vaarkamp, H. and Fink-Gremmels, J. (2006): Biofilms: A role in recurrent mastitis infections? Vet. J. 171, 398-407.
13. Moon, J., Lee, A., Kang, H., Lee, E., Joo, Y., Park, Y. H., Kim, M. and Koo, H. (2007): Antibiogram and coagulase diversity in staphylococcal enterotoxin-producing Staphylococcus aureus from bovine mastitis. J. Dairy Sci. 90, 1716-1724.
14. Oliveira, M., Bexiga, R., Nunes, S., Carneiro, C., Cavaco, L., Bernardo, F. and Vilela, C. (2006): Biofilm-forming ability profiling of Staphylococcus aureus and Staphylococcus epidermidis mastitis isolates. Vet. Microbiol. 118, 133-140.
15. Park, Y., Koo, H., Kim, S., Hwang, S., Jung, W., Kim, J., Shin, S., Kim, R. and Park, Y. H. (2007): The analysis of milk components and pathogenic bacteria isolated from bovine raw milk in Korea. J. Dairy Sci. 90, 5405-5414.
16. Park, Y. K., Jung, S.-I., Park, K.-H., Cheong, H. S., Peck, K. R., Song, J.-H. and Ko, K. S. (2009): Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea. Diagn. Micr. Infec. Dis. 64, 43-51.
17. Roy-Burman, A., Savel, R. H., Racine, S., Swanson, B. L., Revadigar, N. S., Fujimoto, J., Sawa, T., Frank, D. W. and Wiener-Kronish, J. P. (2001): Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J. Infect. Dis. 183, 1767-1774.
18. Selezska, K., Kazmierczak, M., Musken, M., Garbe, J., Schobert, M., Haussler, S., Wiehlmann, L., Rohde, C. and Sikorski, J. (2012): Pseudomonas aeruginosa population structure revisited under environmental focus: impact of water quality and phage pressure. Environ. Microbiol. 14, 1952-1967.
19. Spilker, T., Coenye, T., Vandamme, P. and LiPuma, J. J. (2004): PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients. J. Clin. Microbiol. 42, 2074-2079.
20. Sumathi, B. R., Veeregowda, B. M. and Gomes, A. R. (2008): Prevalence and antibiogram profile of bacterial isolates from clinical bovine mastitis. Vet. World 1, 237-238.
21. Szmolka, A., Cramer, N. and Nagy, B. (2012): Comparative genomic analysis of bovine, environmental and human strains of Pseudomonas aeruginosa. FEMS Microbiol. Lett. 335, 113-122.
22. Vance, R. E., Rietsch, A. and Mekalanos, J. J. (2005): Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo. Infect. Immun. 73, 1706-1713.
23. Wiehlmann, L., Wagner, G., Gramer, N., Siebert, B., Gudowius, P., Morales, G., Kohler, T., Van Delden, C., Weinel, C. and Slickers, P. (2007): Population structure of Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 104, 8101-8106.